1. Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells
   Kateřina Kratochvílová et al, 2015, Int. J. Cancer CrossRef
2. Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung
   JIUN KANG, 2015 CrossRef
3. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation.
   Elisabeth Mohorko et al, 2014, Structure CrossRef
4. TUSC3: a novel tumour suppressor gene and its functional implications
   Xinshuang Yu et al, 2017, J. Cell. Mol. Med. CrossRef
5. TUSC3: functional duality of a cancer gene
   Kateřina Vašíčková et al, 2017, Cell. Mol. Life Sci. CrossRef
6. Role of protein glycosylation in cancer metastasis
   Leticia Oliveira-Ferrer et al, 2017, Seminars in Cancer Biology CrossRef
7. Oncogenic function of TUSC3 in non-small cell lung cancer is associated with Hedgehog signalling pathway
   Ye Gu et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
8. TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells
   Siyang Feng et al, 2018, Experimental Cell Research CrossRef
9. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC
   Young-Jun Jeon et al, 2018, Nat Commun CrossRef
10. regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors
    Gary Wilk et al, 2018, PLoS Genet CrossRef
11. TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.
    Peter Horak et al, 2014, Sci Rep CrossRef
12. Tumor suppressor candidate TUSC3 expression during rat testis maturation.
    Ahmed Magzoub Khalid et al, 2013, Biosci. Biotechnol. Biochem. CrossRef
13. X-linked immunodeficiency with magnesium defect, Epstein–Barr virus infection, and neoplasia disease
    Juan Ravell et al, 2014, Current Opinion in Pediatrics CrossRef
14. TUSC3 suppresses glioblastoma development by inhibiting Akt signaling
    Zhenfeng Jiang et al, 2016, Tumor Biol. CrossRef
15. Homozygous single base deletion inTUSC3causes intellectual disability with developmental delay in an Omani family
    Ahmed Al-Amri et al, 2016, Am. J. Med. Genet. CrossRef
16. Effects of RNAi-mediated TUSC3 silencing on radiation-induced autophagy and radiation sensitivity of human lung adenocarcinoma cell line A549 under hypoxic condition
    Ya-Guang Li et al, 2016, Tumor Biol. CrossRef
17. SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis
    Kuancan Liu et al, 2017, Mol Cancer CrossRef
18. UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells
    Kenzui Taniue et al, 2019, Oncogene CrossRef
19. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection
    Hiroko Ideo et al, 2020, Sci Rep CrossRef
20. Tumour suppressor candidate 3 inhibits biological function and increases endoplasmic reticulum stress of melanoma cells WM451 by regulating AKT/GSK3‐β/β‐catenin pathway
    Shoujie Wang et al, 2020, Cell Biochem Funct CrossRef
21. TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling
    Yun Peng et al, 2017, Oncotarget CrossRef
22. Tumor suppressor candidate 3: A novel grading tool and predictor of clinical malignancy in human gliomas
    Jing Yuan et al, 2018, Oncol Lett CrossRef
23. PWAS: proteome-wide association study—linking genes and phenotypes by functional variation in proteins
    Nadav Brandes et al, 2020, Genome Biol CrossRef
24. TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma
    Youji Yan et al, 2019, Oncol Lett CrossRef
25. Oxidoreductases in Glycoprotein Glycosylation, Folding, and ERAD
    Chaitanya Patel et al, 2020, Cells CrossRef
26. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer
    Jianbo Pan et al, 2020, Nat Commun CrossRef
27. Intact cell mass spectrometry coupled with machine learning reveals minute changes induced by single gene silencing
    Lukáš Pečinka et al, 2024, Heliyon CrossRef